FN2 Earnings Intelligence
Align Technology, Inc. earnings overview
Latest Align Technology, Inc. (ALGN) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.
Align Technology, Inc.
The quarter provides mixed evidence for a durable growth case: record Clear Aligner shipments and multiple product and workflow initiatives support demand, while lower Q4 and FY2026 guidance, softer consumers, and ASP pressure argue for caution.
Align Technology, Inc.
The quarter supports a mixed view: resilient aligner demand and international expansion strengthen the growth case, but scanner mix, North American softness, and execution risks temper confidence in a uniformly positive outlook.
Align Technology, Inc.
Align Technology delivered a strong Q1 2026, with revenue of $1.04 billion (up 6.2% YoY) and EPS of $2.58, beating consensus on both the top and bottom lines. Record Invisalign shipments of 686,000 cases and higher average selling prices drove the upside, with international markets delivering double-digit growth. Gross margins expanded to 70.8% GAAP and 71.8% non-GAAP, supported by operational efficiencies, lower refinement rates, and higher-margin NOAA/Zero-AA configurations. Management reaffirmed full-year FY2026 guidance while acknowledging macro uncertainties including the Middle East conflict. Despite the fundamental beat, shares declined on an abnormal basis post-earnings, suggesting the market had already priced in a strong quarter or was focused on forward risk factors.
Align Technology, Inc.
The latest analysis supports a constructive but qualified view: international clear-aligner growth, digital workflow products, DSO partnerships and improved guidance strengthen the growth case, while North American retail weakness, pricing pressure and China VBP remain material counterweights.
Align Technology, Inc.
The supplied evidence weakens the near-term growth case: demand and case conversion deteriorated, guidance sentiment was lowered and restructuring became a priority. The longer-term thesis remains dependent on product adoption, channel expansion and a recovery in financing-supported demand.
Align Technology, Inc.
The current analysis supports a constructive but qualified view: product adoption, DSO expansion and new digital-dentistry offerings support growth, while ASP, FX, tariff and demand risks remain material tests of the trajectory.
Align Technology, Inc.
The supplied analysis supports a cautiously constructive operating thesis: product innovation, international volume, digital workflows and DSO expansion can support growth, but the case depends on managing FX, tariff, competitive and execution pressures while converting launches into durable U.S. and international demand.
Align Technology, Inc.
The supplied analysis points to a mixed quarter: international clear-aligner demand and Systems & Services growth supported the business, while U.S. weakness, pricing pressure, and restructuring-related costs limited the near-term picture. The longer-term case depends on successful product adoption and execution.
Get the ALGN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.